ExploreWatchlistsPricing
  1. JP-listed companies
  2. 3-D Matrix,Ltd.
  3. Financials
  4. Revenue growth (%)

3-D Matrix,Ltd. (7777)

Market cap
¥55B
P/E ratio
59.5x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Apr 30, 202551.1-48.01%
Apr 30, 202498.3+83.29%
Apr 30, 202353.6+14.01%
Apr 30, 202247-10.13%
Apr 30, 202152.3-49.90%
Apr 30, 2020104.5+138.32%
Apr 30, 201943.8-169.72%
Apr 30, 2018-62.9-118.82%
Apr 30, 2017334.2+692.88%
Apr 30, 201642.2-711.76%
Apr 30, 2015-6.9-102.94%
Apr 30, 2014234.7-341.73%
Apr 30, 2013-97.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat